Literature DB >> 27284485

Acute myeloid leukemia masquerading as hepatocellular carcinoma.

Ghaith F Abu-Zeinah1, Paul Weisman1, Karuna Ganesh1, Seth S Katz1, Ahmet Dogan1, Ghassan K Abou-Alfa1, Eytan M Stein1, William Jarnagin1, Michael J Mauro1, James J Harding1.   

Abstract

Hepatocellular carcinoma (HCC) is often diagnosed on the basis of high quality imaging without a biopsy in the cirrhotic liver. This is a case of a 64-year-old Caucasian man with no history of liver disease or cirrhosis that presented with fatigue, weight loss, and abdominal distension and was found to have a large, isolated liver mass with arterial enhancement and portal venous washout on triple-phase computed tomography (CT) suspicious for HCC. The patient was initially referred for a surgical evaluation. Meanwhile, he developed fevers, pancytopenia, and worsening back pain, and a subsequent spinal MRI revealed a heterogeneous bone marrow signal suspicious for metastatic disease. A bone marrow biopsy that followed was diffusely necrotic. A core biopsy of the patient's liver mass was then performed and was diagnostic of acute monocytic-monoblastic leukemia. Findings from peripheral flow cytometry and a repeat bone marrow biopsy were also consistent with this diagnosis, and induction chemotherapy with cytarabine and idarubicin was initiated. This case describes a rare presentation of myeloid sarcoma (MS) as an isolated, hypervascular liver mass that mimics HCC in its radiographic appearance. Due to the broad differential for a liver mass, a confirmatory biopsy should routinely be considered prior to surgical intervention.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); acute myeloid leukemia; myeloid sarcoma (MS)

Year:  2016        PMID: 27284485      PMCID: PMC4880775          DOI: 10.21037/jgo.2015.12.01

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  24 in total

1.  Resection of hepatocellular carcinoma without preoperative tumor biopsy.

Authors:  I Levy; P D Greig ; S Gallinger ; B Langer ; M Sherman
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

2.  MR imaging of hypervascular lesions in the cirrhotic liver: a diagnostic dilemma.

Authors:  Daniella B Parente; Renata M Perez; Antonio Eiras-Araujo; Jaime A Oliveira Neto; Edson Marchiori; Carolina P Constantino; Viviane B Amorim; Rosana S Rodrigues
Journal:  Radiographics       Date:  2012 May-Jun       Impact factor: 5.333

3.  Acute myeloid leukemia presenting as obstructive jaundice caused by granulocytic sarcoma.

Authors:  Joo Young Lee; Wan Suk Lee; Min Kyu Jung; Seong Woo Jeon; Chang Min Cho; Won Young Tak; Young Oh Kweon; Sung Kook Kim; Yong Hwan Choi; Jong Gwang Kim; Sang Kyun Sohn
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

4.  Nonleukemic myeloid sarcoma of the liver: a case report and review of literature.

Authors:  Xiao-Feng Hang; Hai-Guang Xin; Lei Wang; Wen-Sheng Xu; Jun-Xue Wang; Wu Ni; Xiong Cai; Rui-Qi Zhang
Journal:  Hepatol Int       Date:  2011-01-15       Impact factor: 6.047

5.  TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.

Authors:  Frank G Rücker; Richard F Schlenk; Lars Bullinger; Sabine Kayser; Veronica Teleanu; Helena Kett; Marianne Habdank; Carla-Maria Kugler; Karlheinz Holzmann; Verena I Gaidzik; Peter Paschka; Gerhard Held; Marie von Lilienfeld-Toal; Michael Lübbert; Stefan Fröhling; Thorsten Zenz; Jürgen Krauter; Brigitte Schlegelberger; Arnold Ganser; Peter Lichter; Konstanze Döhner; Hartmut Döhner
Journal:  Blood       Date:  2011-12-20       Impact factor: 22.113

6.  Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.

Authors:  J C Byrd; R B Weiss; D C Arthur; D Lawrence; M R Baer; F Davey; E S Trikha; A J Carroll; R Tantravahi; M Qumsiyeh; S R Patil; J O Moore; R J Mayer; C A Schiffer; C D Bloomfield
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

7.  Acute myeloid leukaemia presenting as cholestatic hepatitis.

Authors:  F A Wandroo; J Murray; D Mutimer; S Hubscher
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

8.  Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.

Authors:  Michael H Tomasson; Zhifu Xiang; Richard Walgren; Yu Zhao; Yumi Kasai; Tracie Miner; Rhonda E Ries; Olga Lubman; Daved H Fremont; Michael D McLellan; Jacqueline E Payton; Peter Westervelt; John F DiPersio; Daniel C Link; Matthew J Walter; Timothy A Graubert; Mark Watson; Jack Baty; Sharon Heath; William D Shannon; Rakesh Nagarajan; Clara D Bloomfield; Elaine R Mardis; Richard K Wilson; Timothy J Ley
Journal:  Blood       Date:  2008-02-12       Impact factor: 22.113

9.  Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia.

Authors:  Apostolia-Maria Tsimberidou; Hagop M Kantarjian; Sijin Wen; Michael J Keating; Susan O'Brien; Mark Brandt; Sherry Pierce; Emil J Freireich; L Jeffrey Medeiros; Elihu Estey
Journal:  Cancer       Date:  2008-09-15       Impact factor: 6.860

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  3 in total

1.  Liver Granulocytic Sarcoma With Megakaryocytic Differentiation: A Rare Extra Medullary Involvement That Warrants Liver Biopsy for Prompt Diagnosis.

Authors:  Hira Chaudhary; Haytham Aboushi; Jeremy Minkowitz; Jodi-Ann Edwards; Daniel Beltre; Priyanka Parmar; Igal Breitman; Carol Luhrs; Samy I McFarlane
Journal:  Cureus       Date:  2021-07-13

2.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma.

Authors:  Tim F Greten; Ghassan K Abou-Alfa; Ann-Lii Cheng; Austin G Duffy; Anthony B El-Khoueiry; Richard S Finn; Peter R Galle; Lipika Goyal; Aiwu Ruth He; Ahmed O Kaseb; Robin Kate Kelley; Riccardo Lencioni; Amaia Lujambio; Donna Mabry Hrones; David J Pinato; Bruno Sangro; Roberto I Troisi; Andrea Wilson Woods; Thomas Yau; Andrew X Zhu; Ignacio Melero
Journal:  J Immunother Cancer       Date:  2021-09       Impact factor: 13.751

3.  Acute hepatitis-like presentation with cholestasis of CBFB-MYH11-positive acute myeloid leukemia in an adult male: a case report.

Authors:  Irene Spinelli; Adriano De Santis; Laura Cesini; Mara Riminucci; Alessandro Corsi; Mariana Forlino; Elio Pietro Perrone; Clara Minotti; Claudio Cartoni
Journal:  J Med Case Rep       Date:  2022-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.